NemaLife Awarded NIH Grant for the Development of Postbiotics and Probiotics
NemaLife Inc., a TechBio company focused on nutritional bioactive development and pre-clinical research, has secured a grant from the National Center for Complementary and Integrative Health (NCCIH), part of the NIH, to advance bioactive solutions using beneficial microbes. This funding supports NemaLife’s AI-powered organism-on-chip platform, using C. elegans to demonstrate the health benefits of nutritional bioactives. As a Nobel Prize-winning model that naturally feeds on bacteria, C. elegans is ideal for gut microbiome research. Its simple gut structure allows faster, cost-effective bacterial screening, offering more relevant insights than rodent or in vitro models.
NemaLife Awarded NIH Grant for the Development of Postbiotics and Probiotics